FRI0388 SECUKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS, IRRESPECTIVE OF TIME SINCE FIRST DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM

التفاصيل البيبلوغرافية
العنوان: FRI0388 SECUKINUMAB IMPROVES HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH ANKYLOSING SPONDYLITIS, IRRESPECTIVE OF TIME SINCE FIRST DIAGNOSIS: POOLED RESULTS FROM THE SECUKINUMAB PHASE 3 TRIAL PROGRAM
المؤلفون: Deodhar, Atul, Boonen, Annelies, Ferraccioli, Gianfranco, Bosch, Filip van den, Martinez, David, Porter, Brian, Shete, Abhijit, Gilloteau, Isabelle, Yocolly, Aurore, Strand, Vibeke
المصدر: Spondyloarthritis – treatment
بيانات النشر: BMJ Publishing Group Ltd and European League Against Rheumatism
سنة النشر: 2019
نوع الوثيقة: conference object
اللغة: unknown
DOI: 10.1136/annrheumdis-2019-eular.2829
الإتاحة: https://doi.org/10.1136/annrheumdis-2019-eular.2829Test
رقم الانضمام: edsbas.E0DE8116
قاعدة البيانات: BASE
الوصف
DOI:10.1136/annrheumdis-2019-eular.2829